Testosterone Gel May Lower Diabetes Risk
Testosterone gel is a prescription steroid that usually used to treat low levels of testosterone in men. But new studies found that Testosterone gel can also lower the risk of diabetes particularly type 2 diabetes.
According to a new study funded by the British drugmaker ProStrakan Group, testosterone gel therapy can repair the fundamental problems in men who suffer from type 2 diabetes.
Type 2 Diabetes occurs when the body’s cells can not response to insulin normally or called insulin resistance.
The researchers found that applying testosterone gel can reduce insulin resistance in diabetic men who had low testosterone levels, or men without diabetes but with a cluster of heart disease risk factors called metabolic syndrome.
Testosterone gel therapy can also lower bad cholesterol levels and had some positive impact on sexual function.
“These findings support the treatment of testosterone in men with low testosterone and type 2 Diabetes or metabolic syndrome,” explained Dr T. Hugh Jones of Barnsley Hospital in England at the journal of Diabetes Care.
In this new study, the researchers tested ProStrakan’s testosterone gel against dummy (placebo) gel in 220 middle-aged and older men. The participants used the gel once a day for a year. As a result, insulin resistance decreased by 16 percent in men who used testosterone gel.
However, the testosterone gel can only be used for treatment of diabetes, not as a medicine to control blood sugar levels.
The researchers also found that participants were slightly increased sexual function with testosterone gel, but there was no difference in erectile dysfunction or sexual satisfaction as a whole.
The side effects of testosterone gel were similar to dummy gel, although testosterone may sometimes cause swelling around the joints and in breast.